Two different mRNAs are transcribed from a single genomic locus encoding the chicken erythrocyte anion transport proteins (band 3)

Possibility of Venous Serum Cl- Concentration ([Cl-]s) as a Marker for Human Metabolic Status: Correlation of [Cl-]s to Age, Fasting Blood Sugar (FBS), and Glycated Hemoglobin (HbA1c)

The HCO₃⁻ concentration in venous serum ([HCO₃⁻]_s) is a factor commonly used for detecting the body pH and metabolic conditions. To exactly detect [HCO₃⁻]_s, the venous CO₂ pressure should be kept as it is in the vein. The [HCO₃⁻]_s measurement is technically complicated to apply for huge numbers of almost heathy persons taking only basic medical examinations. The summation of [HCO₃⁻]_s and the venous serum Cl⁻ concentration ([Cl⁻]_s) is approximately constant; therefore, we studied if [Cl⁻]_s could be a marker detecting metabolic conditions instead of [HCO₃⁻]_s. Venous blood was obtained from persons taking basic medical examinations (the number of persons = 107,630). Older persons showed higher values of [Cl⁻]_s, fasting blood sugar (FBS), and glycated hemoglobin (HbA1c) than younger ones. [Cl⁻]_s showed positive correlation to age and negative correlation to FBS and HBA1c. The negative correlation of [Cl⁻]_s to FBS/HbA1c was obvious in persons with high FBS/HbA1c, leading us to an idea that persons with high FBS/HbA1c show high [HCO₃⁻]_s, which might be caused by low activity of carbonic anhydrase in the lung observed in persons with diabetes mellitus under acidotic conditions. Taken together, an easily measured serum electrolyte, [Cl⁻]_s, could be a useful marker estimating metabolic conditions.

Characterization of the deoxyhemoglobin binding site on human erythrocyte band 3: implications for O2 regulation of erythrocyte properties

Band 3, the major protein of the human erythrocyte membrane, associates with multiple metabolic, ion transport, and structural proteins. Functional studies demonstrate that the oxygenation state of the erythrocyte regulates cellular properties performed by these and/or related proteins. Because deoxyhemoglobin, but not oxyhemoglobin, binds band 3 reversibly with high affinity, these observations raise the hypothesis that hemoglobin might regulate erythrocyte properties through its reversible, oxygenation-dependent association with band 3. To explore this hypothesis, we have characterized the binding site of deoxyHb on human erythrocyte band 3. We report that (1) deoxyHb binds to residues 12-23 of band 3; (2) mutation of residues on either side of this sequence greatly enhances affinity of deoxyHb for band 3, suggesting that evolution of a higher affinity interaction would have been possible had it been beneficial for survival; (3) Hb does not bind to 2 other sequences in band 3 despite their high sequence homology to residues 12-23, and (4) the Hb binding site on band 3 lies proximal to binding sites for glycolytic enzymes, band 4.1 and ankyrin, suggesting possible mechanisms through which multifarious erythrocyte properties might be regulated by the oxygenation state of the cell.

Modulation of red cell glycolysis: interactions between vertebrate hemoglobins and cytoplasmic domains of band 3 red cell membrane proteins

Several vital functions/physical characteristics of erythrocytes (including glycolysis, the pentose phosphate pathway, ion fluxes, and cellular deformability) display dependence on the state of hemoglobin oxygenation. The molecular mechanism proposed involves an interaction between deoxyhemoglobin and the cytoplasmic domain of the anion-exchange protein, band 3 (cdB3). Given that band 3 also binds to membrane proteins 4.1 and 4.2, several kinases, hemichromes, and integral membrane proteins, and at least three glycolytic enzymes, it has been suggested that the cdB3-deoxyhemoglobin interaction might modulate the pathways mediated by these associated proteins in an O(2)-dependent manner. We have investigated this mechanism by synthesizing 10-mer peptides corresponding to the NH(2)-terminal fragments of various vertebrate cdB3s, determining their effects on the oxygenation reactions of hemoglobins from the same and different species and examining binding of the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase to the erythrocytic membrane of mouse erythrocytes. The cdB3 interaction is strongly dependent on pH and the number of negative and positive charges of the peptide and at the effector binding site, respectively. It lowers the O(2) association equilibrium constant of the deoxygenated (Tense) state of the hemoglobin and is inhibited by magnesium ions, which neutralize cdB3's charge and by 2,3-diphosphoglycerate, which competes for the cdB3-binding site. The interaction is stronger in humans (whose erythrocytes derive energy predominantly from glycolysis and exhibit higher buffering capacity) than in birds and ectothermic vertebrates (whose erythrocytes metabolize aerobically and are poorly buffered) and is insignificant in fish, suggesting that its role in the regulation of red cell glycolysis increased with phylogenetic development in vertebrates.

Early embryonic expression of ion channels and pumps in chick and Xenopus development

An extensive body of literature implicates endogenous ion currents and standing voltage potential differences in the control of events during embryonic morphogenesis. Although the expression of ion channel and pump genes, which are responsible for ion flux, has been investigated in detail in nervous tissues, little data are available on the distribution and function of specific channels and pumps in early embryogenesis. To provide a necessary basis for the molecular understanding of the role of ion flux in development, we surveyed the expression of ion channel and pump mRNAs, as well as other genes that help to regulate membrane potential. Analysis in two species, chick and Xenopus, shows that several ion channel and pump mRNAs are present in specific and dynamic expression patterns in early embryos, well before the appearance of neurons. Examination of the distribution of maternal mRNAs reveals complex spatiotemporal subcellular localization patterns of transcripts in early blastomeres in Xenopus. Taken together, these data are consistent with an important role for ion flux in early embryonic morphogenesis; this survey characterizes candidate genes and provides information on likely embryonic contexts for their function, setting the stage for functional studies of the morphogenetic roles of ion transport.

Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3

The red blood cell membrane (RBCM) is a primary model for animal cell plasma membranes. One of its major organizing centers is the cytoplasmic domain of band 3 (cdb3), which links multiple proteins to the membrane. Included among its peripheral protein ligands are ankyrin (the major bridge to the spectrin-actin skeleton), protein 4.1, protein 4.2, aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphofructokinase, deoxyhemoglobin, p72syk protein tyrosine kinase, and hemichromes. The crystal structure of cdb3 is reported at 0.26 nm (2.6 Å) resolution. A tight symmetric dimer is formed by cdb3; it is stabilized by interlocked dimerization arms contributed by both monomers. Each subunit also includes a larger peripheral protein binding domain with an α+  β-fold. The binding sites of several peripheral proteins are localized in the structure, and the nature of the major conformational change that regulates membrane-skeletal interactions is evaluated. An improved structural definition of the protein network at the inner surface of the RBCM is now possible.

Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3

The red blood cell membrane (RBCM) is a primary model for animal cell plasma membranes. One of its major organizing centers is the cytoplasmic domain of band 3 (cdb3), which links multiple proteins to the membrane. Included among its peripheral protein ligands are ankyrin (the major bridge to the spectrin-actin skeleton), protein 4.1, protein 4.2, aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphofructokinase, deoxyhemoglobin, p72syk protein tyrosine kinase, and hemichromes. The crystal structure of cdb3 is reported at 0.26 nm (2.6 Å) resolution. A tight symmetric dimer is formed by cdb3; it is stabilized by interlocked dimerization arms contributed by both monomers. Each subunit also includes a larger peripheral protein binding domain with an α+  β-fold. The binding sites of several peripheral proteins are localized in the structure, and the nature of the major conformational change that regulates membrane-skeletal interactions is evaluated. An improved structural definition of the protein network at the inner surface of the RBCM is now possible.

Variant chicken kidney AE1 anion exchanger transcripts are derived from a single promoter by alternative splicing

Previous studies have demonstrated that three variant transcripts, AE1-3, AE1-4 and AE1-5, are derived from the AE1 gene in chicken kidney. These variant transcripts encode AE1 anion exchangers that possess alternative N-terminal cytoplasmic domains. To determine the mechanisms involved in generating these transcripts, a genomic clone, containing the unique sequences at the 5' ends of the AE1-4 and AE1-5 transcripts, was isolated. Characterization of this clone revealed that the sequences at the 5' ends of the AE1-3, AE1-4 and AE1-5 transcripts were each present with an approx. 1.2-kb BamHI fragment of the chicken AE1 gene. RNA blotting and RNase protection analyses using probes derived from this genomic clone have shown that the AE1-4 variant corresponds to the approx. 4.5-kb chicken kidney AE1 transcript, while the AE1-5 variant corresponds to the approx. 5.1-kb transcript. These studies have shown that the AE1-5 transcript extends further 5' than had been previously shown from cDNA cloning studies, and contains the sequence present at the 5' end of the AE1-4 transcript. In addition, primer extension analyses have shown that the variant kidney AE1 transcripts initiate transcription from a common site. This result indicates that the expression of the AE1-3, AE1-4, and AE1-5 transcripts is regulated by a single promoter, P3, that is distinct from the P1 and P2 erythroid-specific promoters of the chicken AE1 gene.

Variant AE2 anion exchanger transcripts accumulate in multiple cell types in the chicken gastric epithelium

Molecular analyses have resulted in the isolation of two chicken stomach AE2 anion exchanger cDNAs, AE2-1 and AE2-2. The approximately 4.3-kilobase (kb) AE2-1 cDNA contains an open reading frame that encodes a predicted polypeptide of approximately 135 kDa that is homologous to AE2 anion exchangers from other species. The partial approximately 1.7-kb AE2-2 cDNA, which differs from the AE2-1 cDNA in two regions, would be predicted to encode an AE2 polypeptide with an alternative N-terminal cytoplasmic tail. Examination of the distribution of these variant transcripts has revealed that AE2 transcripts ranging in size from approximately 4.4 to approximately 7.3 kb accumulate in various adult tissues. However, in the stomach, the unique sequence at the 5'-end of AE2-1 is preferentially associated with transcripts that range in size from approximately 4.5 to approximately 4.9 kb, while the unique sequence at the 5'-end of AE2-2 is preferentially associated with the approximately 7.3-kb AE2 RNA species. In situ hybridization analyses have further revealed that AE2 transcripts accumulate to very high levels within the acid-secreting epithelial cells of the profound gland in the stomach and, to a lesser extent, within the mucus-secreting cells of the superficial gland that line the stomach lumen. This result suggests that AE2 anion exchangers are involved in the regulation of intracellular pH in each of these gastric epithelial cell types.

Four variant chicken erythroid AE1 anion exchangers. Role of the alternative N-terminal sequences in intracellular targeting in transfected human erythroleukemia cells

Four variant AE1 anion exchangers with predicted molecular masses of approximately 99, approximately 102, approximately 104, and approximately 108 kDa are expressed in chicken erythroid cells. These variant polypeptides differ in sequence only at the N terminus of their cytoplasmic domains. Molecular analyses have shown that transcripts derived from both of the erythroid-specific promoters, P1 and P2, encode all four of these AE1 anion exchanger variants. However, quantitative RNase protection analyses have shown that the transcripts derived from the P1 promoter are much more prevalent than those derived from the P2 promoter. Reverse transcriptase polymerase chain reaction studies have indicated that the extensive diversity in the transcripts derived from the AE1 gene occurs both in primitive and definitive lineage erythroid cells. Transient transfection analyses using human erythroleukemia cells have investigated the functional significance of the alternative sequences at the N terminus of these variant exchangers. These studies have shown that the erythroid AE1 variants are sorted to different membrane compartments in these cells. The approximately 99- and approximately 102-kDa variants are primarily sorted to the plasma membrane, whereas the approximately 108-kDa variant is retained in a perinuclear compartment. These results suggest that the alternative N-terminal cytoplasmic sequences of these polypeptides may serve as signals to direct these variant transporters to different membrane compartments within cells.

Molecular characterization of mouse monoclonal antibody BIII.136 and the epitope recognized by the antibody in human band 3 protein

The monoclonal antibody BIII.136, which recognizes the cytoplasmic part of the band 3 protein from human erythrocytes, also detects products of proteolytic degradation of that protein caused by endogeneous proteases in erythrocytes. Now we extend and confirm these observations by finding that in very young erythrocytes from patients with hemolytic anemias the band 3 protein is almost intact, which suggests that proteolytic degradation of that protein proceeds in vivo during the life span f the erythrocyte. Interesting properties and applicability of this antibody for following the band 3 degradation in vivo and for detection of the band 3 variant forms have prompted us to characterize its primary structure and the epitope recognized in band 3. A set of solid phase-synthesized peptides allowed us to establish that MAb BIII.136 is directed against sequence EDPDIP, which corresponds to amino acid residues 22-27 in band 3 protein. Replacement analysis revealed that only E22 and P24 can be replaced by several other amino acids without a significant loss of reactivity, while the remaining four amino acids seem to be an essential part of the epitope. No reactivity of the antibody with band 3 from several other species was found. Analysis of the heavy and light chain variable region cDNAs revealed that the VH is encoded by a member of VH8(VH3609) family, while the VL is encoded by a member of the Vk12/13 family.

Isolation and characterization of the chicken c-sno gene

We have cloned and analyzed the chicken c-sno (cellular ski novel) gene. The promoter region and all of the intron/exon boundaries have been sequenced. The gene is approx. 12-kb long and contains six exons, the first of which is noncoding. The amino-acid sequences encoded in this first coding exon of c-sno and c-ski are highly related; however, the remainder of these two genes appears to be unrelated. Although there is evidence that the transcripts of mammalian c-sno are alternatively spliced, there is no evidence that chicken c-sno is alternatively spliced. The promoter region has a high G + C content and contains neither a TATAA nor a CAAT box. Potential binding sites for the transcription factors SP1, AP1 and AP2, are present upstream from the transcription start point.

Unlike its human counterpart, band 3 anion exchange protein from goat erythrocyte membrane shows a lack of reactivity against various -SH oxidants and protease treatments

Studies involving a number of -SH oxidants and proteases were made to analyse the organization of band 3 in goat erythrocyte membrane. -SH oxidizing agents such as diamide, Cu2+.o-phenanthroline and phenylene dimaleimide, known to cause cross-linking of human erythrocyte band 3, failed to show any cross-linking in the case of goat band 3 protein. When resolved to their individual components using -SH reducing agent beta-mercaptoethanol, high molecular weight protein adducts formed as a result of diamide treatment did not show any band 3 on two-dimensional electrophoresis. Also no proteolysis of band 3 was detected when intact goat erythrocytes were exposed to pronase, though marked proteolysis was noticed in the case of human band 3 proteins under similar conditions. These studies involving -SH oxidant and protease treatments suggest a different organization for goat erythrocyte band 3 protein as compared to that of human in erythrocyte membrane.

Role of N-glycosylation in the expression of human band 3-mediated anion transport

The human erythrocyte anion transporter (band 3; AE1) has a single N-linked glycosylation site at amino residue Asn-642. To investigate the functional role of the N-glycan in band 3 (b3) we have constructed mutant b3 cDNAs in which this residue has been replaced by Gly, Ser or Thr, and the expression of these mutants was examined in Xenopus oocytes. Chymotrypsin treatment of intact oocytes was used to assess surface b3. Similar amounts of cleavage were observed with both glycosylated and unglycosylated b3. Greater cleavage of b3 was obtained when human red cell glycophorin A (GPA) was co-expressed with either glycosylated or unglycosylated b3. The co-expression of GPA with either glycosylated or unglycosylated b3 increased the stilbene disulphonate-sensitive chloride transport into oocytes at low cRNA concentrations. In both the presence or absence of GPA, a higher b3-mediated chloride influx into oocytes was observed on expression of glycosylated b3 cRNA compared with similar amounts of unglycosylated b3 cRNA. We suggest that glycosylation is not essential for the expression of functional b3 in oocytes, but may play a role in enabling the protein to acquire its correct folding with the highest anion transport activity.

The major integral proteins of the human red cell

The structures and functions of the major human red cell integral membrane proteins are summarized in this review. The proteins that are discussed are the anion transporter (band 3), the sialic acid-rich glycophorins and the glucose transporter. Band 3 (AE1) is a member of a family of anion transporters which carry out Cl-/HCO3- exchange. AE1 is largely restricted to red cells and functions in CO2 transport between the tissues and lungs. In addition to its transport function band 3 acts as an anchor site to the membrane of the red cell skeleton, and also binds a number of cytoplasmic red cell proteins. Variant forms of band 3 are known and some of these have an effect on red cell function and viability. The glycophorins comprise three major proteins, glycophorin A (GPA), glycophorin B (GPB) and glycophorin C (GPC). GPA and GPB (together with another putative gene product, GPE) are closely related products of highly homologous genes located in tandem on the human chromosome. The similarity between the genes gives rise to a number of genetic variants as a result of unequal crossover events. The gene products are erythroid specific. The function of the proteins is not clearly established, but GPA appears to have a role in facilitating the movement of band 3 to the cell surface during the biosynthesis of the latter. The GPC gene is not related to the GPA, GPB and GPE gene family. This gene gives rise to GPC and a form of GPC which is truncated at the N-terminus and is designated GPD. GPC functions in anchoring the red cell skeleton to the membrane, and absence of the protein is associated with red cell abnormalities. GPC transcripts are found in many other tissues, where they probably also have a role in cytoskeletal interactions. The red cell glucose transporter (GLUT1) is a member of the gene family of passive glucose transporters. GLUT1 is not erythroid specific but is also present in several other tissues.

Control of cell pH in immature primitive red cells from chick embryo

1. The intracellular pH in primitive red cells from 4 day chick embryos was measured with the digitonin null-point method and the fluorescent indicator SNARF-1. At physiological pHe of 8.0 red cell pH is 7.39 at day 4. 2. The calculated proton equilibrium potential of -38 mV is in good agreement with previous measurements of Em (Engelke et al., 1988) and supports the conclusion that the Em is dominated by a proton conductance. 3. The sodium-proton exchanger is present in primitive red cells but quiescent under physiological conditions. 4. The results indicate that the bicarbonate-chloride exchange via Band 3 protein is impaired.

Complete nucleotide sequence of band 3 related anion transport protein AE2 from human kidney

The cDNA coding for the complete human band 3 related anion exchange protein AE2 has been cloned from human kidney mRNA. The protein is encoded by a mRNA of approx. 3885 nucleotides containing an open reading frame of 3720 nucleotides. The AE2 protein consists of 1240 amino acid residues and has a molecular mass of 136,805 Da.

Correction of erythrocyte abnormalities in idiopathic calcium-oxalate nephrolithiasis and reduction of urinary oxalate by oral glycosaminoglycans

Calcium-oxalate nephrolithiasis is associated with a defect in erythrocyte oxalate self-exchange and an abnormal rate of erythrocyte membrane protein phosphorylation. There is evidence that glycosaminoglycans (GAGs) have a regulatory effect on both of these processes. This study tested the hypothesis that modifications of erythrocyte oxalate self-exchange induced by oral GAGs are paralleled by similar changes in overall oxalate metabolism. 40 patients with idiopathic calcium-oxalate nephrolithiasis were treated for 15 days with 60 mg/day of a mixture of GAGs. By day 15 of treatment there were significant reductions from baseline in erythrocyte oxalate self-exchange (mean [SD] 1.67 [1.18] vs 2.59 [1.63] x 10(2) per min; p less than 0.005) and erythrocyte membrane protein phosphorylation (55.8 [7.3] vs 72.9 [6.8] x 10(-3) cpm/mg protein; p less than 0.005), but also in urinary oxalate excretion (0.24 [0.09] vs 0.31 [0.15] mmol/24 h; p less than 0.005). This finding suggests similar changes in both erythrocytes and other cells more important in oxalate handling. The changes had reversed by 15 days after withdrawal of treatment. Acute intravenous administration of GAGs (60 mg) induced a fall in carbon-14-labelled oxalate renal clearance (143 [13] vs 169 [28] ml/min; p less than 0.005), which strongly suggests the participation of the kidney. However, reduced oxalate absorption from the intestine, and even decreased synthesis of oxalate, cannot be ruled out.

Molecular biology of the anion exchanger gene family

The gene family of anion exchangers consists of at least four or five members, of which three have been characterized at the cDNA level. AE1-3 encode polypeptides that share significant homology with the erythrocyte anion exchanger, band 3 (AE1). Expression of cDNAs encoding these genes in heterologous systems confirms that this sequence similarity is reflected in the capacity to mediate reversible Cl/HCO3 exchange. While the NH2-terminal domain of band 3 is known to interact with several cytoplasmic proteins in erythrocytes, the function of the analogous domains of AE2 and AE3 remains unknown. The AE1 gene is expressed coordinately with other erythroid genes during erythropoiesis in both avian and mammalian erythroid progenitor cells. In addition, AE1 is expressed at the basolateral plasma membrane of the acid-secreting intercalated cells of the kidney. AE2 is expressed in a number of epithelial and nonepithelial cells; it may be expressed in the Golgi apparatus of some of these cells. AE3 is expressed in excitable tissues, including neurons and muscle. It is likely that these proteins play a role in regulation of intracellular pH and chloride in their respective tissue. Understanding of the physiological roles of these proteins, both for ion transport and for plasma membrane organization, remains a central issue.

Isolation and characterization of the rainbow trout erythrocyte band-3 protein

Rainbow trout (Salmo gairdneri) band-3 protein was isolated from trout erythrocyte plasma membranes by a combination of preparative SDS/PAGE and electroelution. High purity and recovery of the plasma membranes were achieved by a new method. This was demonstrated using 4,4'diiso-thiocyano[3H2]dihydro-stilbene 2,2'disulfonic acid (3H2DIDS) which specifically labels band-3 protein. On SDS/PAGE, band-3 protein yields a similarly diffuse pattern, as does mammalian band-3 protein, with an apparent Mr of 116,000. In situ chymotryptic cleavage/cross-linking experiments with 3H2DIDS reveal that the fragments cross-link as in human and mouse band-3 proteins but that there are minor differences. Treatment of trout erythrocytes with trypsin results in cleavage of the band-3 protein. Purified polyclonal antibodies raised against trout band-3 protein react with trout band-3 protein and do not crossreact with mouse or human band-3 protein. They react specifically with only one chymotryptic fragment of trout band-3 protein.